Inosine
規格
58-63-9CAS番号
200-390-4EC番号
9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-oneIUPAC名
C10H12N4O5化学式
268.23 g/mol分子量
inosine; 58-63-9; Hypoxanthosine; Ribonosine; Atorel; Oxiamin; Hypoxanthine riboside; Trophicardyl; Selfer; 9-beta-D-Ribofuranosylhypoxanthine; Hypoxanthine D-riboside; Hypoxanthine ribonucleoside; Hypoxanthine nucleoside; Inosina; Inosinum; Inotin; INO 495; DTXSID2045993; 5A614L51CT; NSC-20262; 9-beta-D-ribofuranosyl-9H-purin-6-ol; DTXCID0025993; CHEBI:17596; 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one; 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one; 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-3H-purin-6-one; 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-1H-purin-6-one; 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6,9-dihydro-1H-purin-6-one; 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6,9-dihydro-3H-purin-6-one; RefChem:791048; D06BB05; G01AX02; S01XA10; 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-3H-purin-6-one; 200-390-4; Panholic-L; Pantholic-L; (-)-Inosine; Inosie; iso-prinosine; Inosine [INN:JAN]; Inosinum [INN-Latin]; Inosina [INN-Spanish]; hypoxanthine-ribose; INO; MFCD00066770; Hypoxanthine, 9-beta-D-ribofuranosyl-; Inosin; AI3-52241; HXR; Hypoxanthine-9-beta-D-ribofuranoside; NSC 20262; beta-D-Ribofuranoside, hypoxanthine-9; Hypoxanthine 9-beta-D-ribofuranoside; MLS000028518; 9.beta.-D-Ribofuranosylhypoxanthine; 1,9-Dihydro-9-beta-D-ribofuranosyl-6H-purin-6-one; 9-.beta.-D-Ribofuranosylhypoxanthine; SMR000058316; 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one; .beta.-Inosine; 9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3H-purin-6(9H)-one; CAS-58-63-9; SR-01000721862; EINECS 200-390-4; Carnine; Catacol; Hypoxanthosine;; NSC20262; Trophicardyl;; UNII-5A614L51CT; Oxiamine;; 3h-inosine; D-Inosine; Inosie;; 2ada; 2fqw; .beta.-D-Ribofuranoside, hypoxanthine-9; NCGC00095787-01; Adenosine Imp. G (EP); Inosine; Didanosine Imp. B (Ph. Int.); 9-beta-D-Ribofuranosyl-1,9-dihydro-6H-purin-6-one; Adenosine Impurity G; Didanosine Impurity B; Hypoxanthine, 9-.beta.-D-ribofuranosyl-; Inotin (TN); Hypoxanthine riboside;; CID 5274258; Inosine (JAN/INN); 1a4m; Inosine (8CI,9CI); INOSINE [INN]; INOSINE [JAN]; INOSINE [MI]; INOSINE [MART.]; Opera_ID_1628; INOSINE [WHO-DD]; INOSINE [WHO-IP]; bmse000098; bmse000888; bmse000978; cid_6021; CHEMBL1556; SCHEMBL15804; KBioGR_002560; KBioSS_002569; INOSINE [USP IMPURITY]; GTPL4554; orb1224575; orb1310617; orb3025449; SCHEMBL1682742; SCHEMBL3365586; SCHEMBL6933022; 9-b-D-Ribofuranosylhypoxanthine; Hypoxanthine-9-D-ribofuranoside; Inosine, >=99% (HPLC); SCHEMBL18653532; 9beta-D-Ribofuranosylhypoxanthine; BDBM22104; KBio2_002560; KBio2_005128; KBio2_007696; KBio3_003038; 9-|A-D-Ribofuranosylhypoxanthine; 9-b-D-ribofuranosyl-Hypoxanthine; MSK6812; 9-|_-D-Ribofuranosylhypoxanthine; cMAP_000084; HMS2235I17; Hypoxanthine-9-delta-ribofuranoside; 9-beta-D-ribofuranosyl-Hypoxanthine; HY-N0092; 9beta-delta-Ribofuranosylhypoxanthine; Tox21_111522; BDBM50366815; beta-D-Ribofuranoside hypoxanthine-9; EBC-44242; EBC-47437; hypoxanthine-9 beta-D-Ribofuranoside; 9-beta-delta-Ribofuranosylhypoxanthine; (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-hydroxypurin-9-yl)oxolane-3,4-diol; AKOS015969695; AKOS015995607; AKOS024462561; Atorel; HXR; Hypoxanthine D-riboside; Tox21_111522_1; 9-beta-delta-ribofuranosyl-Hypoxanthine; CCG-267127; CS-5845; DB04335; DIDANOSINE IMPURITY B [WHO-IP]; NI06297; 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3H-purin-6-one; beta-delta-Ribofuranoside hypoxanthine-9; Hypoxanthine 9-beta-delta-ribofuranoside; hypoxanthine-9 beta-delta-Ribofuranoside; Hypoxanthine-9-beta-delta-ribofuranoside; SMP1_000165; NCGC00095787-05; NCGC00095787-06; NCGC00096119-02; NCGC00096119-03; AS-11754; BP-51105; SY005000; 9-(beta-D-ribofuranosyl)-9H-purin-6-ol; ADENOSINE IMPURITY G [EP IMPURITY]; DB-029916; DIDANOSINE IMPURITY B [EP IMPURITY]; I0037; NS00010210; C00294; D00054; EN300-310328; 1,9-dihydro-9-b-D-ribofuranosyl-6H-Purin-6-one; I538583; Q422564; SR-01000721862-2; SR-01000721862-3; AC89F8E4-FD89-45EE-8B41-94DFC07AB42F; BRD-K79612754-001-19-1; BRD-K79612754-001-21-7; 1,9-Dihydro-9-beta-delta-ribofuranosyl-6H-purin-6-one; 6H-Purin-6-one, 1,9-dihydro-9-beta-D-ribofuranosyl-; Z2681890654; Inosine; Adenosine EP Impurity G; Didanosine EP Impurity B; 9-.BETA.-D-RIBOFURANOSYL-1,9-DIHYDRO-6H-PURIN-6-ONE; 9-beta-D-Ribofuranosyl-1,9-dihydro-6H-purin-6-one (Inosine); 9-.BETA.-D-RIBOFURANOSYL-1,9-DIHYDRO-6H-PURIN-6-ONE [WHO-IP]; (2R,3R,4S,5R)-2-(6-hydroxy-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-3,4-diol; 9-(3,4-DIHYDROXY-5-HYDROXYMETHYL-TETRAHYDRO-FURAN-2-YL)-1,9-DIHYDRO-PURIN-6-ONE; 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-purin-6-one; 478182-32-0; 9-|A-D-Ribofuranosylhypoxanthine; 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one; InChI=1/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s別名
Inosineを含む製品
Inosineを販売する企業
HD
Hangzhou Dingyan Chem Co., LtdChinaSI
Sinoway Industrial Co.Ltd.ChinaKC
KIVIPHARM CO.,LTD.ChinaCP
CISEN PHARMACEUTICAL CO.,LTD.ChinaZC
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.ChinaHS
Hainan Shuangcheng Pharmaceuticals Co.,Ltd.ChinaTP
Tuoxin Pharmaceutical group Co., LtdChinaCI
China Isotope Development Co.,LtdChinaAC
AFINE CHEMICALS LIMITED